~~<i id='29CCC40ED1'><strike id='29CCC40ED1'><tt id='29CCC40ED1'><pre id='29CCC40ED1'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

comprehensive

author：comprehensive 2025-10-02 12:41:55 - browse：844

Two business miniatures talk to each other on coin stacks that are sandwiched by a syringe and a stethoscope — coverage from STAT — Adobe

For all the flak they get, the country’s four biggest pharmacy benefit managers reported a surprisingly tame average profit margin in the first three quarters of 2023: 4.5%, less than a third of their drugmaker peers.

But don’t take their numbers as gospel, experts warned.

“It’s really easy to move money around inside the books of a vertically integrated organization,” said Karen Van Nuys, a senior fellow at the USC Schaeffer Center for Health Policy and Economics. “If one segment of your vertically integrated organization is not publishing any financial data, it’s a good place to hide stuff.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： How a small hospital in rural Puerto Rico survived Hurricane Maria

explore

hotspot

focus

knowledge

SamuelCorum/GettyImagesThere’sapharmacyintheWhiteHouse—or,atleast,there’sasignthatsays“Pharmacy,”tho

WSS

Health Care Service Corp to buy Cigna Medicare Advantage plans

Why Medicare shouldn’t cover every FDA

Biogen walks away from Aduhelm, years after polarizing approval

Black vets could get higher VA benefits if race not used in lung test

White House pharmacy plagued with problems, investigation finds

PBM executives asked to testify by House panel

focus

comprehensive

explore

Continuity nursing helped my family in our darkest PICU moments

Pancreatic cancer early detection could be helped by AI

Peter Hotez and the public health issue of online harassment

Syphilis numbers in the United States reach record heights

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Venture capital firm's plans to take over Akron hospital face hurdles

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Brain MRIs reveal impact of 'toxic stress' on Black children

Wildfire smoke exposes gaps in outdoor worker protections

Merck CEO won’t testify in Senate, citing no expertise in drug prices

hotspot

Chemotherapy before breast cancer surgery might fuel metastasis

HHS's proposed rule does nothing to address the climate crisis

The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

As billionaires fund anti

Warren pushes Witty on UnitedHealth's control over physicians

Readout Newsletter: The latest on Novavax, Merck, Bluebird

hotspot

hotspot

focus

knowledge